Lumexa Imaging Holdings, Inc. (LMRI)

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Commercial Insurance Revenue	445.71M	408.36M
Commercial Insurance Revenue Growth	9.15%	-6.22%
Government - Medicare Revenue	179.60M	172.63M
Government - Medicare Revenue Growth	4.04%	-0.31%
Government - Medicaid Revenue	35.91M	32.05M
Government - Medicaid Revenue Growth	12.04%	-2.07%
Attorney Liens Revenue	31.76M	27.11M
Attorney Liens Revenue Growth	17.14%	-2.60%
Self-Pay Revenue	26.13M	27.34M
Self-Pay Revenue Growth	-4.43%	-9.69%
Other Third-Party Payors Revenue	47.59M	48.07M
Other Third-Party Payors Revenue Growth	-0.99%	-0.45%
Net Patient Service Revenue - Unrelated Party	766.70M	715.56M
Net Patient Service Revenue - Unrelated Party Growth	7.15%	-4.30%
Net Patient Service Revenue - Related Party	36.01M	31.29M
Net Patient Service Revenue - Related Party Growth	15.09%	59.21%
Total Net Patient Service Revenue	802.71M	746.85M
Total Net Patient Service Revenue Growth	7.48%	-2.68%
Management Fee and Other Revenue	220.37M	202.02M
Management Fee and Other Revenue Growth	9.09%	19.87%
Revenue (Total)	1.02B	948.87M
Revenue (Total) Growth	7.82%	1.38%

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Outpatient Revenue	761.49M	707.46M
Outpatient Revenue Growth	7.64%	1.49%
Professional Revenue	271.39M	248.40M
Professional Revenue Growth	9.25%	1.69%
Eliminations from Revenue	-9.80M	-6.99M
Revenue (Total)	1.02B	948.87M
Revenue (Total) Growth	7.82%	1.38%

Adjusted EBITDA

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Outpatient Adjusted EBITDA	191.41M	172.54M
Outpatient Adjusted EBITDA Growth	10.93%	9.47%
Professional Adjusted EBITDA	38.75M	28.30M
Professional Adjusted EBITDA Growth	36.93%	-28.46%
Operating Income (Total)	97.90M	55.24M
Operating Income (Total) Growth	77.22%	146.13%

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023
Consolidated Outpatient Same-Center Revenue Growth	-	7.70%	-1.20%
Consolidated Outpatient Same-Center Volume Growth	-	5.40%	-2.80%
Consolidated Outpatient Same-Center Net Revenue per Scan Growth	-	2.20%	1.70%
Consolidated Professional Same-Practice Revenue Growth	-	8.70%	2.50%
Consolidated Professional Same-Practice Volume Growth	-	5.40%	1.90%
Consolidated Professional Same-Practice Net Revenue per Read Growth	-	3.10%	0.60%
System-Wide Revenue Growth	-	8.20%	3.20%
System-Wide Outpatient Same-Center Revenue Growth	-	7.80%	4.20%
System-Wide Outpatient Same-Center Volume Growth	-	3.60%	-0.30%
System-Wide Outpatient Same-Center Net Revenue per Scan Growth	-	4.00%	4.50%
Number of Outpatient Imaging Centers in Operation	189.00	188.00	181.00
Number of Outpatient Imaging Centers in Operation Growth	0.53%	3.87%	-1.09%
Number of Outpatient Imaging Centers with a Health System Joint Venture Partner	86.00	86.00	83.00
Number of Outpatient Imaging Centers with a Health System Joint Venture Partner Growth	-	3.61%	1.22%
Number of Consolidated Outpatient Imaging Centers	103.00	102.00	98.00
Number of Consolidated Outpatient Imaging Centers Growth	0.98%	4.08%	-2.97%

Data Source: Fiscal.ai Last updated: May 12, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 29, 2026

Data Sources Report a data error